RecruitingPhase 2NCT05568498

Probiotic Treatment for Depression and Associated Mood Disorders in Parkinson's Disease

Sponsor

University of British Columbia

Enrollment

60 participants

Start Date

Jan 20, 2025

Study Type

INTERVENTIONAL

Conditions

Depression Parkinson Disease PARKINSON DISEASE (Disorder)

Summary

This study evaluates the use of an oral multi-strain probiotic in the treatment of depression in individuals with Parkinson's Disease. Participants will be randomized to either a 12-week multi-strain probiotic treatment or placebo intervention.

Eligibility

Min Age: 40 YearsMax Age: 80 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying Placebo and Probiotic for people with depression, parkinson disease (disorder), and other related conditions. The study is currently recruiting participants at 1 location. People eligible for this study include aged 40 Years to 80 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.